• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒诱导的miR-181a减少通过双特异性磷酸酶6的过表达损害CD4(+) T细胞反应。

Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6.

作者信息

Li Guang Y, Zhou Yun, Ying Ruo S, Shi Lei, Cheng Yong Q, Ren Jun P, Griffin Jeddidiah W D, Jia Zhan S, Li Chuan F, Moorman Jonathan P, Yao Zhi Q

机构信息

Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN.

出版信息

Hepatology. 2015 Apr;61(4):1163-73. doi: 10.1002/hep.27634. Epub 2015 Feb 4.

DOI:10.1002/hep.27634
PMID:25477247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4376593/
Abstract

UNLABELLED

T cells play a crucial role in viral clearance or persistence; however, the precise mechanisms that control their responses during viral infection remain incompletely understood. MicroRNA (miR) has been implicated as a key regulator controlling diverse biological processes through posttranscriptional repression. Here, we demonstrate that hepatitis C virus (HCV)-mediated decline of miR-181a expression impairs CD4(+) T-cell responses through overexpression of dual specific phosphatase 6 (DUSP6). Specifically, a significant decline of miR-181a expression along with overexpression of DUSP6 was observed in CD4(+) T cells from chronically HCV-infected individuals compared to healthy subjects, and the levels of miR-181a loss were found to be negatively associated with the levels of DUSP6 overexpression in these cells. Importantly, reconstitution of miR-181a or blockade of DUSP6 expression in CD4(+) T cells led to improved T-cell responses including enhanced CD25 and CD69 expression, increased interleukin-2 expression, and improved proliferation of CD4(+) T cells derived from chronically HCV-infected individuals.

CONCLUSION

Since a decline of miR-181a concomitant with DUSP6 overexpression is the signature marker for age-associated T-cell senescence, these findings provide novel mechanistic insights into HCV-mediated premature T-cell aging through miR-181a-regulated DUSP6 signaling and reveal new targets for therapeutic rejuvenation of impaired T-cell responses during chronic viral infection.

摘要

未标记

T细胞在病毒清除或持续存在中起关键作用;然而,病毒感染期间控制其反应的精确机制仍未完全了解。微小RNA(miR)已被认为是通过转录后抑制控制多种生物学过程的关键调节因子。在此,我们证明丙型肝炎病毒(HCV)介导的miR-181a表达下降通过双特异性磷酸酶6(DUSP6)的过表达损害CD4(+) T细胞反应。具体而言,与健康受试者相比,在慢性HCV感染个体的CD4(+) T细胞中观察到miR-181a表达显著下降以及DUSP6过表达,并且发现这些细胞中miR-181a缺失水平与DUSP6过表达水平呈负相关。重要的是,在CD4(+) T细胞中重建miR-181a或阻断DUSP6表达导致T细胞反应改善,包括增强的CD25和CD69表达、增加的白细胞介素-2表达以及慢性HCV感染个体来源的CD4(+) T细胞增殖改善。

结论

由于miR-181a下降与DUSP6过表达同时出现是与年龄相关的T细胞衰老的标志性标志物,这些发现为HCV介导的通过miR-181a调节的DUSP6信号通路导致的T细胞过早衰老提供了新的机制见解,并揭示了慢性病毒感染期间受损T细胞反应治疗性恢复活力的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/31597c53a8cd/nihms649404f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/0330c69fb5a0/nihms649404f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/f429f5dc442e/nihms649404f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/b19ba643e5c1/nihms649404f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/6f98c4186c2d/nihms649404f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/1df376deae2b/nihms649404f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/31597c53a8cd/nihms649404f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/0330c69fb5a0/nihms649404f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/f429f5dc442e/nihms649404f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/b19ba643e5c1/nihms649404f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/6f98c4186c2d/nihms649404f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/1df376deae2b/nihms649404f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a6f/4376593/31597c53a8cd/nihms649404f6.jpg

相似文献

1
Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6.丙型肝炎病毒诱导的miR-181a减少通过双特异性磷酸酶6的过表达损害CD4(+) T细胞反应。
Hepatology. 2015 Apr;61(4):1163-73. doi: 10.1002/hep.27634. Epub 2015 Feb 4.
2
Protection of CD4+ T cells from hepatitis C virus infection-associated senescence via ΔNp63-miR-181a-Sirt1 pathway.通过ΔNp63- miR-181a-Sirt1途径保护CD4 + T细胞免受丙型肝炎病毒感染相关的衰老
J Leukoc Biol. 2016 Nov;100(5):1201-1211. doi: 10.1189/jlb.5A0316-119RR. Epub 2016 Jun 27.
3
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity.随着年龄的增长,miR-181a 表达的下降通过增加 DUSP6 活性损害 T 细胞受体的敏感性。
Nat Med. 2012 Oct;18(10):1518-24. doi: 10.1038/nm.2963. Epub 2012 Sep 30.
4
Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.丙型肝炎病毒介导的微小RNA miR-373增强会损害JAK/STAT信号通路。
J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.
5
Defects in Antiviral T Cell Responses Inflicted by Aging-Associated miR-181a Deficiency.衰老相关的 miR-181a 缺陷导致抗病毒 T 细胞反应缺陷。
Cell Rep. 2019 Nov 19;29(8):2202-2216.e5. doi: 10.1016/j.celrep.2019.10.044.
6
T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.具有CD4+CD25+调节表型的T细胞在慢性丙型肝炎病毒感染期间可抑制病毒特异性CD8+T细胞的体外增殖。
J Virol. 2005 Jun;79(12):7860-7. doi: 10.1128/JVI.79.12.7860-7867.2005.
7
Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.丙型肝炎病毒核心蛋白可引发慢性丙型肝炎患者体内CD4(+)CD25(+)调节性T细胞的扩增与激活。
Cell Mol Immunol. 2015 Nov;12(6):743-9. doi: 10.1038/cmi.2014.119. Epub 2014 Dec 22.
8
The GSK3β-β-catenin-TCF1 pathway improves naive T cell activation in old adults by upregulating miR-181a.GSK3β-β-连环蛋白-TCF1通路通过上调miR-181a改善老年人初始T细胞的激活。
NPJ Aging Mech Dis. 2021 Feb 8;7(1):4. doi: 10.1038/s41514-021-00056-9.
9
Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.丙型肝炎患者中miR-122、miR-126、miR-136和miR-181a的肝脏表达及其与组织病理学和临床特征的相关性
J Viral Hepat. 2015 Feb;22(2):146-57. doi: 10.1111/jvh.12266. Epub 2014 Jul 25.
10
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.在丙型肝炎病毒(HCV)感染明显恢复后,与肝脏中HCV持续存在相关的病毒特异性T细胞反应。
J Med Virol. 2006 Sep;78(9):1190-7. doi: 10.1002/jmv.20680.

引用本文的文献

1
ATM in immunobiology: From lymphocyte development to cancer immunotherapy.免疫生物学中的 ATM:从淋巴细胞发育到癌症免疫治疗
Transl Oncol. 2025 Feb;52:102268. doi: 10.1016/j.tranon.2024.102268. Epub 2025 Jan 2.
2
The Role of Epigenetic Mechanisms in the Pathogenesis of Hepatitis C Infection.表观遗传机制在丙型肝炎感染发病机制中的作用。
Biomolecules. 2024 Aug 10;14(8):986. doi: 10.3390/biom14080986.
3
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets.微生物在传染病中的作用:潜在的诊断生物标志物和治疗靶点。

本文引用的文献

1
The role of microRNAs in hepatitis C virus replication and related liver diseases.微小RNA在丙型肝炎病毒复制及相关肝脏疾病中的作用
J Microbiol. 2014 Jun;52(6):445-51. doi: 10.1007/s12275-014-4267-x. Epub 2014 May 29.
2
Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.丙型肝炎病毒对 miR-181c 的转录抑制作用增强了同源盒 A1 的表达。
J Virol. 2014 Jul;88(14):7929-40. doi: 10.1128/JVI.00787-14. Epub 2014 Apr 30.
3
Hepatitis C virus and microRNAs: miRed in a host of possibilities.丙型肝炎病毒与微小RNA:众多可能性中的miRed
Clin Microbiol Rev. 2023 Dec 20;36(4):e0001523. doi: 10.1128/cmr.00015-23. Epub 2023 Nov 1.
4
Analysis of self-renewing and differentiation-related microRNAs and transcription factors in multilineage mouse hematopoietic stem/progenitor cells induced by 1,4-benzoquinone.1,4-苯醌诱导的多能造血干/祖细胞自我更新和分化相关 microRNAs 及转录因子的分析
PeerJ. 2023 Jul 10;11:e15608. doi: 10.7717/peerj.15608. eCollection 2023.
5
A DUSP6 inhibitor suppresses inflammatory cardiac remodeling and improves heart function after myocardial infarction.一种 DUSP6 抑制剂可抑制心肌梗死后的炎症性心脏重构,改善心脏功能。
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.049662. Epub 2022 Dec 7.
6
Mitochondrial topoisomerase 1 inhibition induces topological DNA damage and T cell dysfunction in patients with chronic viral infection.线粒体拓扑异构酶 1 抑制导致慢性病毒感染患者的拓扑 DNA 损伤和 T 细胞功能障碍。
Front Cell Infect Microbiol. 2022 Nov 3;12:1026293. doi: 10.3389/fcimb.2022.1026293. eCollection 2022.
7
Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals.意义重大的微观玩家-宿主 microRNA 特征在人类和动物的病毒感染中。
Int J Mol Sci. 2022 Sep 11;23(18):10536. doi: 10.3390/ijms231810536.
8
Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4CD25FOXP3 Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization.骨髓间充质干细胞来源的外泌体包裹的miR-181a通过SIRT1/乙酰化介导的FOXP3稳定诱导CD4CD25FOXP3调节性T细胞。
J Oncol. 2022 May 26;2022:8890434. doi: 10.1155/2022/8890434. eCollection 2022.
9
Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study.轮状病毒介导的 microRNA-192 家族和 microRNA-181a 的抑制激活 Wnt/β-连环蛋白信号通路:一项体外研究。
Viruses. 2022 Mar 9;14(3):558. doi: 10.3390/v14030558.
10
BCI Suppresses RANKL-Mediated Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss.骨保护素抑制核因子κB受体活化因子配体介导的破骨细胞生成并减轻去卵巢诱导的骨质流失。
Front Pharmacol. 2021 Nov 1;12:772540. doi: 10.3389/fphar.2021.772540. eCollection 2021.
Curr Opin Virol. 2014 Aug;7:1-10. doi: 10.1016/j.coviro.2014.03.004. Epub 2014 Apr 12.
4
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.IFNL3 CT/TT 携带者中 microRNA122 表达降低及慢性丙型肝炎患者纤维化进展过程中。
J Virol. 2014 Jun;88(11):6394-402. doi: 10.1128/JVI.00016-14. Epub 2014 Mar 26.
5
Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockade.在 Tim-3 阻断的情况下,李斯特菌感染的树突状细胞增强了病毒特异性 CD8+ T 细胞反应。
PLoS One. 2014 Jan 31;9(1):e87821. doi: 10.1371/journal.pone.0087821. eCollection 2014.
6
Immune responses to HCV and other hepatitis viruses.对 HCV 和其他肝炎病毒的免疫反应。
Immunity. 2014 Jan 16;40(1):13-24. doi: 10.1016/j.immuni.2013.12.010.
7
KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.KLRG1 通过 p16ink4a 和 p27kip1 通路损害 CD4+ T 细胞应答:在丙型肝炎病毒感染者中乙型肝炎疫苗失败中的作用。
J Immunol. 2014 Jan 15;192(2):649-57. doi: 10.4049/jimmunol.1302069. Epub 2013 Dec 13.
8
Novel therapeutic approaches for hepatitis C.新型丙型肝炎治疗方法。
Clin Pharmacol Ther. 2014 Jan;95(1):78-88. doi: 10.1038/clpt.2013.206. Epub 2013 Oct 14.
9
Emerging concepts in immunity to hepatitis C virus infection.丙型肝炎病毒感染免疫的新观点。
J Clin Invest. 2013 Oct;123(10):4121-30. doi: 10.1172/JCI67714. Epub 2013 Oct 1.
10
Novel therapies for hepatitis C - one pill fits all?新型丙型肝炎治疗方法——一药通用?
Nat Rev Drug Discov. 2013 Aug;12(8):595-610. doi: 10.1038/nrd4050. Epub 2013 Jun 28.